Flagship Ventures Fund V, L.P.'s Net Worth

$360 Million

Estimate Recalculated Feb 20, 2024 05:40PM EST

Who is Flagship Ventures Fund V, L.P.?

Flagship Ventures Fund V, L.P. has an estimated net worth of $360 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Kaleido Biosciences, Inc., Omega Therapeutics, Inc., Foghorn Therapeutics Inc., Denali Therapeutics Inc., Rubius Therapeutics, Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., and Evelo Biosciences, Inc..

SEC CIK

Flagship Ventures Fund V, L.P.'s CIK is 0001627639

Past Insider Trading and Trends

2020 was Flagship Ventures Fund V, L.P.'s most active year for acquiring shares with 17 total transactions. Flagship Ventures Fund V, L.P.'s most active month to acquire stocks was the month of February. 2023 was Flagship Ventures Fund V, L.P.'s most active year for disposing of shares, totalling 18 transactions. Flagship Ventures Fund V, L.P.'s most active month to dispose stocks was the month of July. 2021 saw Flagship Ventures Fund V, L.P. paying a total of $26,089,973.00 for 58,154,228 shares, this is the most they've acquired in one year. In 2023 Flagship Ventures Fund V, L.P. cashed out on 13,527,995 shares for a total of $17,962,115.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.175

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-32.03%
-11.78M
25M
Sep 13
Form 4
-3.22%
-403.76K
$6.27
-$2,532,858.32
12.12M
Jun 6 - Jun 7
Form 4
-4.17%
-545.24K
$6.47
-$3,527,275.14
12.53M
May 24 - May 26
Form 4
34.24M
34.24M
Feb 8
Form 3
0
0
No matching records found

Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.12%
12M
$15.00
$13,999,995.00
37.48M
Mar 4
Form 3
0
0
No matching records found

Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
12.67M
$16.00
12.67M
Oct 27
Form 3
0
0
No matching records found

Denali Therapeutics Inc. (DNLI) Snapshot price: $17.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,754.00%
8.61M
8.92M
Dec 12
Form 3
0
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.89%
210K
$29.00
$6,090,000.00
23.89M
Mar 19
Form 4
+185.29%
33.3M
51.27M
Jul 20
Form 3
0
0
No matching records found